This inventor holds 1 USPTO granted patent. Top assignee: Eniricerche S.p.a.. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Innovations of Ada Velati Bellini: Pioneering Research in Immune System Modulation
Introduction: Ada Velati Bellini is an innovative inventor based in Pavia, Italy, known for her significant contributions to the field of immunology. With one patented invention, she has made strides in the production and application of human beta interleukin-1. Her work has implications for enhancing immune responses and developing treatments for various diseases.
Latest Patents: Ada Velati Bellini holds a patent for the "Expression and secretion of mature human beta interleukin-1 in Bacillus." This patent describes a novel plasmid vector capable of replicating in Bacillus subtilis, which allows for the expression and secretion of human beta interleukin-1. The method developed by Bellini results in a biologically active protein with a specific activity of 1.times.10.sup.9 U/mg of protein. This innovation is particularly impactful as it serves as a potent stimulant for the immune system, adjuvant in vaccines, and a therapeutic agent for autoimmune conditions in humans.
Career Highlights: Ada has leveraged her expertise in biotechnology while working at Eniricerche S.p.a., a company dedicated to innovative research in various sectors. Her analytical skills combined with her creative approach to problem-solving have established her as a key player in her field.
Collaborations: Throughout her career, Ada has collaborated with esteemed colleagues, including Giuliano Galli and Giuseppe Lucchese. These partnerships have further enriched her research and advanced the development of effective immune-modulating solutions.
Conclusion: Ada Velati Bellini's work exemplifies the spirit of innovation within the biotechnology sector. Her patented methods for producing human beta interleukin-1 not only enhance our understanding of immune responses but also pave the way for new treatments for autoimmune diseases and infectious agents. Her contributions embody the potential for science and innovation to address complex health challenges.